PRZOOM - /newswire/ -
Noida, Uttar Pradesh, India, 2010/10/13 - With the increasing number of cancer patients and increasing interests of industry players, the global monoclonal antibodies market for oncology will witness a significant growth in coming years, says RNCOS.
According to our new research report, “Global Monoclonal Antibody Market Analysis”, the market of monoclonal antibodies (mAbs) for the treatment of cancer has been growing incessantly for the past few years. Our study indicates that due to high incidence & subsequent potential for market success, cancer has effectively surfaced in attracting highest levels of R&D. In fact, monoclonal antibodies therapeutics occupied around 30% of market share in 2009 in the global oncology market.
We have identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that rising incidences of cancer coupled with growing health insurance industry will drive renewed interests of the investors in the monoclonal antibodies therapeutics market for oncology at the global level. Further, research and development for expansion of usage of drugs for several indications will further enhance the growth of mAbs oncology market in the coming years.
Besides, our report provides a thorough research and prudent analysis of Global monoclonal antibodies therapeutics market. The systematic and thorough research studies the global monoclonal antibodies therapeutics market to give an insight into its various segments, including Oncology, Autoimmune & Inflammatory Diseases, Respiratory Diseases, Neurological Diseases, and Cardiovascular Diseases. Further, the comprehensive analysis of the market at the regional level, points the United States as the current highest share-holder. However, future will see emerging countries like China & India posting significant growth rates.
"Global Monoclonal Antibody Market Analysis" provides thorough research and rational analysis along with reliable statistics of the Global monoclonal antibodies therapeutics industry. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Besides, an insight of trends prevailing at the regional monoclonal therapeutics market segments across the globe along with analysis of key drugs has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation, and geographic distribution have been thoroughly studied in the report to give a comprehensive view of the market. The report has thoroughly examined market drivers, industrial developments, alliances & acquisitions, and competitive landscape to enable clients understand the market structure and its future progress.
RNCOS (rncos.com) specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.